These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2476917)

  • 1. The influence of a temporary cessation and reperfusion of intestinal blood flow on the level of hepatic lipid peroxides.
    Lutz J; Augustin A
    Adv Exp Med Biol; 1989; 248():803-8. PubMed ID: 2476917
    [No Abstract]   [Full Text] [Related]  

  • 2. Antipyrine kinetics following partial blood exchange with Fluosol-DA in the rat.
    Shrewsbury RP; White SG; Pollack GM; Wargin WA
    J Pharm Pharmacol; 1986 Dec; 38(12):883-7. PubMed ID: 2880960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in-situ absorption of antipyrine as a measure of intestinal blood flow in Fluosol-DA haemodiluted rats.
    Shrewsbury RP; White LG
    J Pharm Pharmacol; 1990 Jul; 42(7):511-2. PubMed ID: 1980296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recovery from pentobarbital-induced sleep after administration of perfluorinated blood substitutes.
    Lutz J; Wagner M
    Artif Organs; 1984 Feb; 8(1):41-3. PubMed ID: 6703925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure to determine heparin concentrations in plasma containing Fluosol-DA using an analytical kit.
    Shrewsbury RP; White LG
    Clin Chim Acta; 1989 Feb; 179(3):347-8. PubMed ID: 2714008
    [No Abstract]   [Full Text] [Related]  

  • 6. Blood substitutes: has the right solution been found?
    Lancet; 1986 Mar; 1(8483):717-8. PubMed ID: 2870227
    [No Abstract]   [Full Text] [Related]  

  • 7. Hemodilution and myocardial oxygen supply. The influence of fluosol-DA.
    Vogel H; Günther H; Harrison DK; Anderer W; Kessler M; Peter K
    Adv Exp Med Biol; 1989; 248():653-61. PubMed ID: 2782181
    [No Abstract]   [Full Text] [Related]  

  • 8. Changes in plasma enzyme concentrations in response to blood substitution with perfluorocarbon emulsion in the conscious rat.
    Lowe KC; McNaughton DC
    Experientia; 1986 Dec; 42(11-12):1228-31. PubMed ID: 3780945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a perfluorocarbon emulsion, Fluosol-DA, on rat lymphoid tissue and immunological competence.
    Bollands AD; Lowe KC
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1986; 85(2):309-12. PubMed ID: 2879690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephrotoxic effects of oxygen transport media in the isolated rat kidney.
    Millis RM; Barber JD; Anderson WA; Gold AJ; Storm CB; Reindorf CA
    Proc Soc Exp Biol Med; 1985 Apr; 178(4):643-7. PubMed ID: 3983140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in intravascular fluid composition following blood replacement with perfluorocarbon emulsion in the rat.
    Lowe KC; McNaughton DC; Hardy RN
    Klin Wochenschr; 1985 Oct; 63(19):1028-34. PubMed ID: 4068605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of different oxygen concentrations during hemodilution with Fluosol or LMW-Dextran in rabbits.
    Beisbarth H; Madjidi A; Frey R
    Prog Clin Biol Res; 1983; 122():373-80. PubMed ID: 6192450
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of varying extents of Fluosol-DA or normal saline haemodilution on the dose dependent kinetics of phenytoin in the rat.
    Shrewsbury RP; Oliver SR; Lewis LM; Anderson WT; White LG
    J Pharm Pharmacol; 1989 Aug; 41(8):582-4. PubMed ID: 2571710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of moderate haemodilution with Fluosol-DA or Hespan on the nonmicrosomal acetylation of sulphadimidine in the rat.
    Shrewsbury RP; Hong DD; White LG; Gordon TR
    J Pharm Pharmacol; 1992 Feb; 44(2):84-8. PubMed ID: 1378493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attempts to increase intratumoral blood flow in the rat solid Walker 256 tumor by the use of the perfluorocarbon emulsion fluosol-DA.
    Klubes P; Hiraga S; Cysyk RL; Owens ES; Blasberg RG
    Eur J Cancer Clin Oncol; 1987 Dec; 23(12):1859-67. PubMed ID: 3436350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral cortical oxygenation and perfusion during progressive normovolaemic haemodilution with hetastarch (volex) and fluosol-DA.
    Shinozuka T; Nemoto EM; Winter PM
    Adv Exp Med Biol; 1987; 215():109-15. PubMed ID: 2445178
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative studies with Fluosol, Dextran, their mixture, or autologous blood in experimental hypovolemic shock.
    Madjidi A; Beisbarth H; Frey R
    Prog Clin Biol Res; 1983; 122():391-7. PubMed ID: 6192451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of Fluosol-DA and Hespan haemodilution on S-warfarin elimination in the rat.
    Shrewsbury RP; Hong DD
    J Pharm Pharmacol; 1990 Sep; 42(9):665-6. PubMed ID: 1706766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of exchange transfusion with perfluorochemical emulsions on hepatic oxygen supply and blood flow in the rat.
    Bizot WB; Rink RD
    Experientia; 1985 Sep; 41(9):1127-9. PubMed ID: 4043318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex-vivo perfusion of surgically removed organs.
    Baba S; Nakai K; Mizutani K
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):623-4. PubMed ID: 3179494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.